Ets-2 Repressor Factor Silences Extrasynaptic Utrophin by N-Box–mediated Repression in Skeletal Muscle
- 1 August 2007
- journal article
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 18 (8) , 2864-2872
- https://doi.org/10.1091/mbc.e06-12-1069
Abstract
Utrophin is the autosomal homologue of dystrophin, the protein product of the Duchenne's muscular dystrophy (DMD) locus. Utrophin expression is temporally and spatially regulated being developmentally down-regulated perinatally and enriched at neuromuscular junctions (NMJs) in adult muscle. Synaptic localization of utrophin occurs in part by heregulin-mediated extracellular signal-regulated kinase (ERK)-phosphorylation, leading to binding of GABPα/β to the N-box/EBS and activation of the major utrophin promoter-A expressed in myofibers. However, molecular mechanisms contributing to concurrent extrasynaptic silencing that must occur to achieve NMJ localization are unknown. We demonstrate that the Ets-2 repressor factor (ERF) represses extrasynaptic utrophin-A in muscle. Gel shift and chromatin immunoprecipitation studies demonstrated physical association of ERF with the utrophin-A promoter N-box/EBS site. ERF overexpression repressed utrophin-A promoter activity; conversely, small interfering RNA-mediated ERF knockdown enhanced promoter activity as well as endogenous utrophin mRNA levels in cultured muscle cells in vitro. Laser-capture microscopy of tibialis anterior NMJ and extrasynaptic transcriptomes and gene transfer studies provide spatial and direct evidence, respectively, for ERF-mediated utrophin repression in vivo. Together, these studies suggest “repressing repressors” as a potential strategy for achieving utrophin up-regulation in DMD, and they provide a model for utrophin-A regulation in muscle.Keywords
This publication has 53 references indexed in Scilit:
- M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2–Sos association and phosphatidylinositol 3-kinase activityCellular Signalling, 2005
- Intracellular expression profiling by laser capture microdissection: three novel components of the neuromuscular junctionPhysiological Genomics, 2005
- CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophyExperimental Cell Research, 2005
- Layer-specific differences of gene expression in extraocular muscles identified by laser-capture microscopyPhysiological Genomics, 2004
- Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF‐AT pathwayThe FASEB Journal, 2004
- Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatmentEMBO Reports, 2004
- Pharmacological strategies for muscular dystrophyNature Reviews Drug Discovery, 2003
- Corepressor-Dependent Silencing of Chromosomal Regions Encoding Neuronal GenesScience, 2002
- Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoterJournal of Molecular Biology, 2001
- Calcium/calmodulin-dependent regulation of the NH2-terminal F-actin binding domain of utrophinFEBS Letters, 1995